An Egg White-Derived Peptide Enhances Systemic Insulin Sensitivity and Modulates Markers of Non-Alcoholic Fatty Liver Disease in Obese, Insulin Resistant Mice

Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, is a global health problem. Currently, no pharmacological treatment is approved for NAFLD. Natural health products, including bioactive peptides, are potential candidates to aid in the management of metab...

Descripción completa

Detalles Bibliográficos
Autores principales: de Campos Zani, Stepheny C., Wang, Ren, Veida-Silva, Hellen, Clugston, Robin D., Yue, Jessica T. Y., Mori, Marcelo A., Wu, Jianping, Chan, Catherine B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965836/
https://www.ncbi.nlm.nih.gov/pubmed/36837793
http://dx.doi.org/10.3390/metabo13020174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965836/
https://www.ncbi.nlm.nih.gov/pubmed/36837793
http://dx.doi.org/10.3390/metabo13020174

Ejemplares similares